Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC, a prominent player in the global pharmaceutical industry, is headquartered in the United States. Founded in 1860, the company has a rich history marked by significant milestones, including its integration into the larger pharmaceutical landscape through mergers and acquisitions. Wyeth operates primarily in the biopharmaceutical sector, focusing on innovative treatments in areas such as immunology, oncology, and vaccines.
The company is renowned for its core products, which include advanced biologics and specialty pharmaceuticals that address critical health needs. Wyeth's commitment to research and development has positioned it as a leader in the market, with notable achievements in vaccine development and chronic disease management. With a strong presence in North America and Europe, Wyeth Pharmaceuticals continues to make strides in improving patient outcomes and advancing healthcare solutions.
+60 vs industry average
Wyeth Pharmaceuticals LLC’s score of 100 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Wyeth Pharmaceuticals LLC?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Wyeth Pharmaceuticals LLC yet.
Wyeth Pharmaceuticals LLC's reported carbon emissions
Wyeth Pharmaceuticals LLC, headquartered in the US, currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of Pfizer Inc., which means that any climate commitments or emissions data may be inherited from its parent organisation.
Pfizer Inc. has established various climate initiatives, including Science-Based Targets Initiative (SBTi) commitments, which are cascaded down to Wyeth Pharmaceuticals. However, specific reduction targets or achievements for Wyeth are not detailed in the available information.
As part of its corporate family, Wyeth Pharmaceuticals is aligned with Pfizer's broader sustainability goals, which include commitments to reduce greenhouse gas emissions across all scopes. The absence of direct emissions data for Wyeth suggests a reliance on Pfizer's overarching strategies and targets to guide its climate actions.
In summary, while Wyeth Pharmaceuticals LLC does not present specific emissions figures or reduction targets, it is positioned within Pfizer's climate framework, which aims to address carbon emissions and promote sustainability across its operations.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Wyeth Pharmaceuticals LLC’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Wyeth Pharmaceuticals LLC yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Pfizer Inc.
Carbon Disclosure Project
Inherited from Pfizer Inc.The Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from Pfizer Inc.RE 100
Inherited from Pfizer Inc.Climate Action 100
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for Wyeth Pharmaceuticals LLC yet.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project